Member Directory

001 Limited are an independent utility specialists with over 20 years of experience in saving money and time for businesses across the UK on energy contracts. They offer a one-stop shop, from procuring energy generated from renewable sources, to validating invoices to ensure suppliers’ billing is correct on a monthly basis.

For more information please visit https://www.001ltd.co.uk/

272BIO Ltd is a specialist biotechnology company which focuses on developing novel biological therapies for veterinary disease areas. 272BIO has an established in vitro laboratory which is based on The Pirbright Institute site, a world-renowned centre of expertise in veterinary disease management and therapy. Biotherapeutics can provide solutions for areas of health which are difficult to tackle with conventional medicines. Traditional Biotherapeutics are becoming more and more common in Human Health due to their selectivity, specificity and flexibility. The cost of development and production of typical monoclonal antibodies all but excludes biotherapeutics from Animal Health. Therapies developed using VHH antibodies retain the positive attributes of antibodies, but at a much lower production cost. This brings biological solutions within the reach of Veterinary Medicine.

A4PBio provide CRO oversight, project management and consultancy services in order to deliver regulatory compliant bioanalysis and bio-logistics solutions to the life science sector. A4PBio offer client-focused solutions in global laboratory selection, through assay development and validation, study sample analysis, data reporting and document review. Combining this with bespoke logistics solutions for the pro-actively managed transport of time and temperature critical biological samples and cell-based therapies. A4PBio's flexible and scalable resources, using considerable Pharmaceutical, Biotechnology and CRO experience, deliver individually built, cost effective, scientifically robust and regulatory compliant outsourcing or consultancy solutions.

As a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster.

Abcam partners with life science organizations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise.

By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company’s pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products.

With twelve sites globally, many of Abcam’s 1,400+ strong team are located in the world’s leading life science research hubs, complementing a global network of services and support.

To discover more, please visit www.abcam.com and www.abcamplc.com.

Actigen focuses on the development of novel biotherapeutics, specifically antibodies and protein-based drugs. . . Operating globally from its base in Cambridge, UK, Actigen is working with an expanding network of academic, scientific and medical experts to progress a number of development projects.

Agenda Life Sciences are experts in life science recruitment, contract staffing, research, facility management, and consultancy services. We excel in delivering exceptional life science staffing solutions for both our valued clients and candidates.

Through partnering with Agenda you receive exceptional facility management that acts as the cornerstone for your early-stage Research & Development initiatives. By leveraging our expertise, we not only save you valuable time and resources but also streamline legislative administration.

Our unwavering commitment to the research community is evident in our dedicated services, designed to seamlessly support and enhance research endeavours.

Agenus, Inc. (www.agenusbio.com) is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body's immune system to benefit cancer patients. By combining multiple powerful platforms, Agenus has established a highly integrated approach for the discovery, development and manufacture of monoclonal antibodies that modulate targets of interest. In addition, Agenus' cancer vaccine programme includes three proprietary platforms focused on individualised and off-the-shelf vaccines uniquely designed for each patient. Agenus' broad portfolio of novel checkpoint and other immuno-modulatory monoclonal antibodies, vaccines and adjuvants work in combination to provide the opportunity to create best-in-class therapeutic regimens.

We support our Clients by navigating through technical challenges, translating data into strategy and communication, and revealing the impact of their science.

Air Liquide UK Limited, part of the world leading Air Liquide Group, provides your single source of expertise for the full range of industrial, laboratory and medical gases and related technologies. We are the preferred supplier for all laboratory gases, with attractive pricing for all Gold members of One Nucleus. Air Liquide UK also offers: specialty gases in cylinders, pressure cans and lecture bottles; dry ice (Cardice®); industrial gases in cylinders; bulk carbon dioxide, air gases (nitrogen, oxygen and argon), and engineering support services.

Pages